Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions

 

 Buy Article Permissions and Reprints

Summary

Fibrin polymerisation is mediated by interactions between knobs ‘A’ and ‘B’ exposed by thrombin cleavage, and holes ‘a’ and ‘b’. We demonstrated markedly delayed thrombin-catalysed fibrin polymerisation, through B:b interactions alone, of recombinant γD364H-fibrinogen with impaired hole ‘a’. To determine whether recombinant variant fibrinogens with no release of fibrinopeptide A (FpA) polymerise similarly to γD364H-fibrinogen, we examined two variant fibrinogens with substitutions altering knob ‘A’, Aα17A- and Aα17C-fibrinogen. We examined thrombin- or batroxobin-catalysed fibrinopeptide release by HPLC, fibrin clot formation by turbidity and fibrin clot structure by scanning electron microscopy (SEM) and compared the results of the variants with those for γD364H-fibrinogen. Thrombin-catalysed FpA release of Aα17A-fibrinogen was substantially delayed and none observed for Aα17C-fibrinogen; fibrinopeptide B (FpB) release was delayed for all variants. All variant fibrinogens showed substantially impaired thrombin-catalysed polymerisation; for Aα17A-fibrinogen it was delayed less, and for Aα17C more than for γD364H-fibrinogen. No variants polymerised with batroxobin, which exposed only knob ‘A’. The inhibition of variant fibrinogens’ polymerisation was dose-dependent on the concentration of either GPRP or GHRP, and both peptides that block holes ‘b’. SEM showed that the variant clots from Aα17A- and γD364H-fibrinogen had uniform, ordered fibres, thicker than normal, whereas Aα17C-fibrinogen formed less organised clots with shorter, thinner, and tapered ends. These results demonstrate that FpA release per se is necessary for effective B:b interactions during polymerisation of variant fibrinogens with impaired A:a interactions.

• References

• 1 Weisel JW. Fibrinogen and fibrin. Adv Protein Chem 2005; 70: 247-299.
  PubMedGoogle Scholar
• 2 Everse SJ, Spraggon G, Veerapandian L. et al. Conformational changes in fragments D and double-D from human fibrin(ogen) upon binding the peptide ligand Gly-His-Arg-Pro-amide. Biochemistry 1999; 38: 2941-2946.
  CrossrefPubMedGoogle Scholar
• 3 Gorkun OV, Veklich YI, Medved LV. et al. Role of the alpha C domains of fibrin in clot formation. Biochemistry 1994; 33: 6986-6997.
  CrossrefPubMedGoogle Scholar
• 4 Yang ZI, Mochalkin I, Doolittle RF. A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides. Proc Natl Acad Sci USA 2000; 97: 14156-14161.
  CrossrefPubMedGoogle Scholar
• 5 Weisel JW, Veklich Y, Gorkun O. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots. J Mol Biol 1993; 232: 285-297.
  CrossrefPubMedGoogle Scholar
• 6 Weisel JW. Fibrin Assembly. Lateral aggregation and the role of the two pairs of fibrinopeptides. Biophys J 1986; 50: 1079-1093.
  CrossrefPubMedGoogle Scholar
• 7 Doolittle RF, Pandi L. Binding of synthetic B-knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin. Biochemistry 2006; 45: 2657-2667.
  CrossrefPubMedGoogle Scholar
• 8 Doolittle RF, Pandi L. Probing the β-chain hole of fibrinogen with synthetic peptides that differ at their amino termini. Biochemistry 2007; 46: 10033-10038.
  CrossrefPubMedGoogle Scholar
• 9 Okumura N, Terasawa F, Haneishi A. et al. B:b interactions are essential for polymerisation of variant fibrinogens with impaired holes ’a’. J Thromb Haemost 2007; 05: 2352-2359.
  CrossrefPubMedGoogle Scholar
• 10 Okumura N, Gorkun OV, Lord ST. Severely impaired polymerisation of recombinant fibrinogen γ-364 Asp-> His, the substitution discovered in a heterozygous individual. J Biol Chem 1997; 272: 29596-29601.
  CrossrefPubMedGoogle Scholar
• 11 Okumura N, Terasawa F, Takezawa Y. et al. Heterozygous Bβ-chain C-terminal 12 amino acid elongation variant, BβX462W (Kyoto VI), showed dysfibrinogenemia. Blood Coagul Fibrinolysis 2012; 23: 87-90.
  CrossrefPubMedGoogle Scholar
• 12 Lewis SD, Shields PP, Shafer JA. Characterisation of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin. J Biol Chem 1985; 260: 10192-10199.
  PubMedGoogle Scholar
• 13 Bowley SR, Merenbloom BK, Okumura N. et al. Polymerisation-defective fibrinogen variant γD364A binds knob “A” peptide mimic. Biochemistry 2008; 47: 8607-8613.
  CrossrefPubMedGoogle Scholar
• 14 Laudano A, Doolittle RF. Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerisation of fibrin monomers. Proc Natl Acad Sci USA 1978; 75: 3085-3089.
  CrossrefPubMedGoogle Scholar
• 15 Litvinov RI, Gorkun OV, Owen SF. et al. Polymerisation of fibrin: specificity strength, and stability of knob-hole interactions studied at the single-molecular level. Blood 2005; 106: 2944-2951.
  CrossrefPubMedGoogle Scholar
• 16 Wada Y, Niwa M, Maekawa H. et al. A new type of congenital dysfibrinogen, fibrinogen Bremen, with an AαGly-17 to Val substitution associated with hemorrhagic diathesis and delayed wound healing. Thromb Haemost 1993; 70: 397-403.
  Article in Thieme ConnectPubMedGoogle Scholar
• 17 Weisel JW, Nagaswami C. Computer modeling of fibrin polymerisation kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. Biophys J 1992; 63: 111-128.
  CrossrefPubMedGoogle Scholar
• 18 Laudano A, Doolittle RF. Influence of calcium ion on the binding of fibrin amino terminal peptides to fibrinogen. Science 1981; 212: 457-459.
  CrossrefPubMedGoogle Scholar
• 19 Soria J, Soria C, Samama M. et al. Fibrinogen Troyes - Fibrinogen Metz. Two new cases of congenital dysfibrinogenemia. Thromb Diath Haemorrh 1972; 27: 619-633.
  PubMedGoogle Scholar
• 20 Galanakis D, Spitzer S, Scharrer I. Unusual Aα16Arg→Cys dysfibrinogenaemic family: absence of normal Aα-chains in fibrinogen from two of four heterozygous siblings. Blood Coagul Fibrinolysis 1993; 04: 67-71.
  CrossrefPubMedGoogle Scholar
• 21 Galanakis DK, Neerman-Arbez M, Scheiner T. et al. Homophenotypic AαR16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B releas. Blood Coagul Fibrinolysis 2007; 18: 731-737.
  CrossrefPubMedGoogle Scholar